Tortoise Investment Management, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 109 filers reported holding G1 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tortoise Investment Management, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,303
-42.2%
2,9880.0%0.00%0.0%
Q2 2023$7,440
-7.1%
2,9880.0%0.00%0.0%
Q1 2023$8,008
-50.6%
2,9880.0%0.00%
-66.7%
Q4 2022$16,225
-56.1%
2,9880.0%0.00%
-57.1%
Q3 2022$37,000
+146.7%
2,9880.0%0.01%
+133.3%
Q2 2022$15,000
-34.8%
2,9880.0%0.00%
-25.0%
Q1 2022$23,000
-25.8%
2,9880.0%0.00%
-33.3%
Q4 2021$31,000
-22.5%
2,9880.0%0.01%
-25.0%
Q3 2021$40,000
-39.4%
2,9880.0%0.01%
-42.9%
Q2 2021$66,000
-8.3%
2,9880.0%0.01%
-12.5%
Q1 2021$72,000
+33.3%
2,9880.0%0.02%
+33.3%
Q4 2020$54,000
+54.3%
2,9880.0%0.01%
+33.3%
Q3 2020$35,000
-51.4%
2,9880.0%0.01%
-52.6%
Q2 2020$72,000
+118.2%
2,9880.0%0.02%
+90.0%
Q1 2020$33,000
-58.2%
2,9880.0%0.01%
-47.4%
Q4 2019$79,000
+16.2%
2,9880.0%0.02%
+5.6%
Q3 2019$68,000
-26.1%
2,9880.0%0.02%
-21.7%
Q2 2019$92,000
+84.0%
2,9880.0%0.02%
+76.9%
Q1 2019$50,000
-12.3%
2,9880.0%0.01%
-13.3%
Q4 2018$57,000
-63.5%
2,9880.0%0.02%
-63.4%
Q3 2018$156,000
+20.0%
2,9880.0%0.04%
+13.9%
Q2 2018$130,000
-37.5%
2,988
-46.7%
0.04%
-37.9%
Q1 2018$208,0005,6110.06%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders